Alembic Pharmaceuticals Ltd
NSE:APLLTD
Alembic Pharmaceuticals Ltd
NSE:APLLTD
Price:
881.25
INR
-0.67%
Market Closed
Market Cap:
173.2B
INR
Balance Sheet
Balance Sheet Decomposition
Alembic Pharmaceuticals Ltd
Alembic Pharmaceuticals Ltd
| Current Assets | 37.6B |
| Cash & Short-Term Investments | 1.4B |
| Receivables | 13B |
| Other Current Assets | 23.2B |
| Non-Current Assets | 34.7B |
| Long-Term Investments | 1B |
| PP&E | 31.2B |
| Other Non-Current Assets | 2.4B |
Balance Sheet
Alembic Pharmaceuticals Ltd
Alembic Pharmaceuticals Ltd
Currency: INR
Millions
Annual
| Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
228
|
4 393
|
1 531
|
837
|
1 991
|
718
|
981
|
611
|
755
|
1 202
|
|
| Cash |
228
|
4 393
|
1 531
|
837
|
1 991
|
718
|
981
|
611
|
755
|
1 202
|
|
| Short-Term Investments |
371
|
127
|
0
|
0
|
0
|
0
|
1 870
|
0
|
0
|
208
|
|
| Total Receivables |
3 829
|
3 682
|
3 568
|
5 534
|
5 036
|
9 122
|
3 795
|
8 452
|
12 338
|
11 861
|
|
| Accounts Receivables |
3 560
|
3 505
|
3 388
|
5 263
|
4 889
|
8 648
|
3 486
|
8 071
|
10 464
|
10 248
|
|
| Other Receivables |
269
|
177
|
180
|
271
|
147
|
474
|
309
|
381
|
1 874
|
1 612
|
|
| Inventory |
4 620
|
6 678
|
7 343
|
8 859
|
10 541
|
12 660
|
15 496
|
16 621
|
15 288
|
17 018
|
|
| Other Current Assets |
169
|
232
|
1 283
|
3 017
|
2 009
|
2 127
|
4 378
|
2 925
|
720
|
705
|
|
| Total Current Assets |
9 217
|
15 113
|
13 725
|
18 247
|
19 577
|
24 628
|
26 520
|
28 608
|
29 100
|
30 786
|
|
| PP&E Net |
5 719
|
8 006
|
11 687
|
18 378
|
24 398
|
30 990
|
36 472
|
39 473
|
29 997
|
30 711
|
|
| PP&E Gross |
5 719
|
8 006
|
11 687
|
18 378
|
24 398
|
30 990
|
36 472
|
39 473
|
29 997
|
30 711
|
|
| Accumulated Depreciation |
3 142
|
3 855
|
1 507
|
2 455
|
3 514
|
4 952
|
6 628
|
8 595
|
10 691
|
13 285
|
|
| Intangible Assets |
0
|
0
|
270
|
1 620
|
2 663
|
2 990
|
3 238
|
1 548
|
0
|
0
|
|
| Goodwill |
0
|
0
|
0
|
38
|
36
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
215
|
300
|
697
|
450
|
149
|
477
|
367
|
349
|
537
|
333
|
|
| Long-Term Investments |
1 060
|
867
|
499
|
416
|
488
|
176
|
493
|
1 184
|
963
|
930
|
|
| Other Long-Term Assets |
0
|
0
|
15
|
262
|
467
|
629
|
0
|
59
|
1 230
|
1 696
|
|
| Other Assets |
0
|
0
|
0
|
38
|
36
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
16 210
N/A
|
24 286
+50%
|
26 893
+11%
|
39 411
+47%
|
47 778
+21%
|
59 891
+25%
|
67 090
+12%
|
71 220
+6%
|
61 828
-13%
|
64 456
+4%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
3 246
|
5 657
|
5 007
|
7 593
|
7 023
|
6 259
|
6 688
|
7 064
|
6 798
|
7 356
|
|
| Accrued Liabilities |
4
|
4
|
4
|
29
|
745
|
675
|
1 171
|
1 042
|
741
|
892
|
|
| Short-Term Debt |
2 071
|
1 138
|
886
|
2 078
|
4 291
|
8 605
|
0
|
4 300
|
6 359
|
4 305
|
|
| Current Portion of Long-Term Debt |
250
|
0
|
0
|
0
|
2 000
|
99
|
3 122
|
2 150
|
169
|
198
|
|
| Other Current Liabilities |
345
|
674
|
1 030
|
1 534
|
837
|
1 878
|
1 828
|
2 610
|
2 302
|
1 799
|
|
| Total Current Liabilities |
5 916
|
7 472
|
6 927
|
11 235
|
14 896
|
17 516
|
12 808
|
17 165
|
16 369
|
14 550
|
|
| Long-Term Debt |
188
|
0
|
0
|
5 000
|
4 993
|
9 603
|
2 714
|
721
|
692
|
629
|
|
| Deferred Income Tax |
240
|
427
|
369
|
354
|
188
|
122
|
42
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
1
|
3
|
8
|
290
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
222
|
413
|
572
|
617
|
521
|
745
|
855
|
958
|
1 062
|
1 095
|
|
| Total Liabilities |
6 567
N/A
|
8 312
+27%
|
7 869
-5%
|
17 209
+119%
|
20 589
+20%
|
27 696
+35%
|
16 420
-41%
|
18 845
+15%
|
18 124
-4%
|
16 274
-10%
|
|
| Equity | |||||||||||
| Common Stock |
377
|
377
|
377
|
377
|
377
|
377
|
393
|
393
|
393
|
393
|
|
| Retained Earnings |
9 219
|
15 528
|
18 565
|
21 744
|
26 653
|
31 583
|
42 800
|
44 491
|
35 687
|
40 273
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
0
|
0
|
7 484
|
7 484
|
7 484
|
7 484
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
6
|
125
|
|
| Other Equity |
48
|
69
|
82
|
80
|
158
|
234
|
7
|
5
|
135
|
158
|
|
| Total Equity |
9 643
N/A
|
15 974
+66%
|
19 023
+19%
|
22 201
+17%
|
27 188
+22%
|
32 194
+18%
|
50 670
+57%
|
52 376
+3%
|
43 705
-17%
|
48 182
+10%
|
|
| Total Liabilities & Equity |
16 210
N/A
|
24 286
+50%
|
26 893
+11%
|
39 411
+47%
|
47 778
+21%
|
59 891
+25%
|
67 090
+12%
|
71 220
+6%
|
61 828
-13%
|
64 456
+4%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
189
|
189
|
189
|
189
|
189
|
189
|
197
|
197
|
197
|
197
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
